No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BLRX BioLine Rx
- 0.203
- +0.001+0.50%
Close Dec 20 16:00 ET
- 0.208
- +0.005+2.66%
Post 20:01 ET
17.07MMarket Cap-0.68P/E (TTM)
0.208High0.197Low921.55KVolume0.205Open0.202Pre Close187.83KTurnover1.20%Turnover RatioLossP/E (Static)84.11MShares1.64052wk High2.01P/B15.63MFloat Cap0.18752wk Low--Dividend TTM77.00MShs Float103.050Historical High--Div YieldTTM5.45%Amplitude0.187Historical Low0.203Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
JonesTrading Maintains BioLine Rx(BLRX.US) With Buy Rating, Maintains Target Price $2
JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)
HC Wainwright & Co. Maintains Buy on BioLine Rx, Lowers Price Target to $9
BioLineRx Ltd. (BLRX) Q3 2024 Earnings Call Transcript
BioLine Rx Q3 2024 GAAP EPS $(0.00) Beats $(0.05) Estimate, Sales $4.94M Miss $5.29M Estimate
Press Release: BioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value
Heat List
US
Overall
Symbol
Price
% Chg
No Data